Christina Weiler-Normann Selected Research

Disease Progression

1/2020	Permanent immunosuppression in SLA/LP-positive autoimmune hepatitis is required although overall response and survival are similar.
1/2018	Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christina Weiler-Normann Research Topics

Disease

18	Autoimmune Hepatitis 01/2022 - 12/2008
4	Sclerosing Cholangitis 10/2020 - 01/2018
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021 - 09/2013
3	Hepatitis 01/2018 - 01/2018
3	Liver Diseases (Liver Disease) 01/2018 - 12/2008
2	Infections 09/2020 - 01/2018
2	Chemical and Drug Induced Liver Injury 01/2020 - 01/2019
2	Disease Progression 01/2020 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 10/2016
2	Cholestasis 01/2018 - 01/2018
2	Fibrosis (Cirrhosis) 01/2018 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 03/2013
1	COVID-19 01/2022
1	End Stage Liver Disease 10/2021
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2021
1	Pruritus (Itching) 01/2021
1	Chronic Hepatitis (Chronic Active Hepatitis) 09/2020
1	Chronic Hepatitis B 09/2020
1	Hepatitis E 09/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Metabolic Bone Diseases (Osteopenia) 01/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Neoplasms (Cancer) 12/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2016
1	Cicatrix (Scar) 10/2016
1	Fatigue 09/2013
1	Disease Susceptibility (Diathesis) 12/2008

Drug/Important Bio-Agent (IBA)

5	AutoantibodiesIBA 01/2021 - 12/2008
4	Immunoglobulin G (IgG)IBA 09/2020 - 03/2013
4	Azathioprine (Imuran)FDA LinkGeneric 01/2020 - 03/2016
2	BilirubinIBA 10/2021 - 01/2018
2	AntibodiesIBA 09/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 03/2013
2	liver antigen LA-1IBA 01/2020 - 12/2008
2	EnzymesIBA 01/2020 - 09/2014
2	Transaminases (Aminotransferases)IBA 01/2018 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2016
2	AutoantigensIBA 07/2012 - 12/2008
1	COVID-19 VaccinesIBA 01/2022
1	obeticholic acidIBA 01/2021
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2021
1	Fibric Acids (Fibrates)IBA 01/2021
1	InterleukinsIBA 10/2020
1	Alanine Transaminase (SGPT)IBA 09/2020
1	CryoglobulinsIBA 09/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Dipyrone (Metamizole)IBA 01/2020
1	Sulfoglycosphingolipids (Sulfatides)IBA 01/2019
1	SteroidsIBA 01/2018
1	CEACAM1 ProteinIBA 01/2018
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2016
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 03/2016
1	Infliximab (Remicade)FDA Link 03/2013
1	Immunoglobulins (Immunoglobulin)IBA 03/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009
1	AntigensIBA 12/2008
1	Peptides (Polypeptides)IBA 12/2008
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2008
1	HLA-DRB1*03:01 antigenIBA 12/2008
1	EpitopesIBA 12/2008

Therapy/Procedure

5	Therapeutics 01/2021 - 03/2013
2	Liver Transplantation 01/2022 - 01/2020
2	Duration of Therapy 01/2020 - 03/2015
2	Aftercare (After-Treatment) 01/2020 - 03/2015
1	Stents 01/2018
1	Sphincterotomy 01/2018
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Transplantation 09/2013